Joel S. Marcus's Insider Trades & SAST Disclosures
Joel S. Marcus's most recent trade in Intra-Cellular Therapies Inc was a trade of 7,009 Common Stock done at an average price of $63.8 . Disclosure was reported to the exchange on Feb. 24, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Joel S. Marcus.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 63.79 per share. | 24 Feb 2025 | 7,009 | 48,238 (0%) | 0% | 63.8 | 447,104 | Common Stock |
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2025 | 7,009 | 0 | - | - | Stock Option (right to buy) | |
| Alexandria Real Estate Equ... | Joel S. Marcus | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 46,207 | 456,144 (0%) | 0% | 0 | Common Stock | |
| Alexandria Real Estate Equ... | Joel S. Marcus | Director, Executive Chairman | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Dec 2024 | 19,156 | 394,327 (0%) | 0% | 0 | Common Stock | |
| Alexandria Real Estate Equ... | Joel S. Marcus | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 15,610 | 409,937 (0%) | 0% | 0 | Common Stock | |
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jun 2024 | 1,567 | 41,229 (0%) | 0% | - | Common Stock | |
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jun 2024 | 1,567 | 0 | - | - | Restricted Stock Units | |
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 4,322 | 4,322 | - | - | Stock Option (right to buy) | |
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 2,951 | 2,951 | - | - | Restricted Stock Units | |
| Applied Therapeutics Inc | Joel S. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 45,000 | 498,414 (2%) | 0% | 0 | Common Stock | |
| Alexandria Real Estate Equ... | Joel S. Marcus | Director, Executive Chairman | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Mar 2024 | 10,655 | 418,883 (0%) | 0% | 0 | Common Stock | |
| Alexandria Real Estate Equ... | Joel S. Marcus | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 128.91 per share. | 29 Mar 2024 | 5,400 | 413,483 (0%) | 0% | 128.9 | 696,114 | Common Stock |
| Intra-Cellular Therapies Inc | Joel Marcus S. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 43.45 per share. | 26 Feb 2024 | 20,000 | 49,233 (0%) | 0% | 43.5 | 869,000 | Common Stock |
| Intra-Cellular Therapies Inc | Marcus Joel S. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2024 | 20,000 | 0 | - | - | Stock Option (right to buy) | |
| Intra-Cellular Therapies Inc | S. Joel Marcus | Director | Sale of securities on an exchange or to another person at price $ 69.07 per share. | 26 Feb 2024 | 17,658 | 39,961 (0%) | 0% | 69.1 | 1,219,638 | Common Stock |
| Intra-Cellular Therapies Inc | S. Marcus Joel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 55.48 per share. | 26 Feb 2024 | 16,757 | 65,990 (0%) | 0% | 55.5 | 929,678 | Common Stock |
| Intra-Cellular Therapies Inc | Marcus S. Joel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2024 | 16,757 | 0 | - | - | Stock Option (right to buy) | |
| Intra-Cellular Therapies Inc | S. Joel Marcus | Director | Sale of securities on an exchange or to another person at price $ 67.83 per share. | 26 Feb 2024 | 8,371 | 57,619 (0%) | 0% | 67.8 | 567,805 | Common Stock |
| Alexandria Real Estate Equ... | Joel Marcus S. | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 118.92 per share. | 26 Feb 2024 | 7,500 | 429,538 (0%) | 0% | 118.9 | 891,900 | Common Stock |
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Sale of securities on an exchange or to another person at price $ 69.60 per share. | 26 Feb 2024 | 299 | 39,662 (0%) | 0% | 69.6 | 20,810 | Common Stock |
| Alexandria Real Estate Equ... | Joel Marcus S. | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2024 | 35,064 | 437,038 (0%) | 0% | 0 | Common Stock | |
| Alexandria Real Estate Equ... | Marcus S. Joel | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 3,000 | 401,974 (0%) | 0% | 0 | Common Stock | |
| Alexandria Real Estate Equ... | S. Marcus Joel | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 47,620 | 398,974 (0%) | 0% | 0 | Common Stock | |
| Applied Therapeutics Inc | Joel S. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2023 | 12,375 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Joel S. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.05 per share. | 15 Sep 2023 | 12,375 | 453,414 (2%) | 0% | 1.1 | 12,994 | Common Stock |
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 7,009 | 7,009 | - | - | Stock Option (right to buy) | |
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 1,567 | 1,567 | - | - | Restricted Stock Units | |
| Applied Therapeutics Inc | Joel S. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 20,000 | 441,039 (2%) | 0% | 0 | Common Stock | |
| Alexandria Real Estate Equ... | Joel S. Marcus | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 122.20 per share. | 08 May 2023 | 7,500 | 351,354 (0%) | 0% | 122.2 | 916,500 | Common Stock |
| Alexandria Real Estate Equ... | Joel S. Marcus | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 125.59 per share. | 31 Mar 2023 | 10,015 | 358,854 (0%) | 0% | 125.6 | 1,257,784 | Common Stock |
| Alexandria Real Estate Equ... | Joel S. Marcus | Director, Executive Chairman | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Mar 2023 | 6,507 | 368,869 (0%) | 0% | 0 | Common Stock | |
| Alexandria Real Estate Equ... | Joel S. Marcus | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 168.00 per share. | 07 Feb 2023 | 9,000 | 388,729 (0%) | 0% | 168 | 1,512,000 | Common Stock |
| Alexandria Real Estate Equ... | Joel S. Marcus | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 160.68 per share. | 27 Jan 2023 | 5,608 | 397,729 (0%) | 0% | 160.7 | 901,093 | Common Stock |
| Alexandria Real Estate Equ... | Joel S. Marcus | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2023 | 24,051 | 403,337 (0%) | 0% | 0 | Common Stock | |
| Alexandria Real Estate Equ... | Joel S. Marcus | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 42,260 | 379,286 (0%) | 0% | 0 | Common Stock | |
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Sale of securities on an exchange or to another person at price $ 50.82 per share. | 19 Dec 2022 | 5,000 | 29,233 (0%) | 0% | 50.8 | 254,100 | Common Stock |
| Alexandria Real Estate Equ... | Joel S. Marcus | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 150.00 per share. | 12 Dec 2022 | 6,500 | 337,026 (0%) | 0% | 150 | 975,000 | Common Stock |
| Alexandria Real Estate Equ... | Joel S. Marcus | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 152.00 per share. | 05 Dec 2022 | 2,500 | 343,526 (0%) | 0% | 152 | 380,000 | Common Stock |
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Sale of securities on an exchange or to another person at price $ 52.11 per share. | 07 Nov 2022 | 5,000 | 34,233 (0%) | 0% | 52.1 | 260,559 | Common Stock |
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Sale of securities on an exchange or to another person at price $ 52.49 per share. | 07 Nov 2022 | 5,000 | 39,233 (0%) | 0% | 52.5 | 262,465 | Common Stock |
| Frequency Therapeutics Inc | Joel S. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2022 | 14,846 | 14,846 | - | - | Stock Option | |
| Frequency Therapeutics Inc | Joel S. Marcus | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Aug 2022 | 14,846 | 0 | - | - | Stock Option | |
| Frequency Therapeutics Inc | Joel S. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2022 | 14,846 | 14,846 | - | - | Stock Option | |
| Frequency Therapeutics Inc | Joel S. Marcus | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Aug 2022 | 14,846 | 0 | - | - | Stock Option | |
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Sale of securities on an exchange or to another person at price $ 59.22 per share. | 11 Aug 2022 | 10,000 | 44,233 (0%) | 0% | 59.2 | 592,200 | Common Stock |
| Applied Therapeutics Inc | Joel S. Marcus | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 16,500 | 16,500 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Joel S. Marcus | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 16,500 | 16,500 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Joel S. Marcus | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 16,500 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Joel S. Marcus | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 16,500 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Joel S. Marcus | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 10,230 | 10,230 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Joel S. Marcus | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 10,230 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Joel S. Marcus | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 7,389 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Joel S. Marcus | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 7,389 | 7,389 | - | - | Employee Stock Option (Right to Buy) | |
| Frequency Therapeutics Inc | Joel S. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 14,846 | 14,846 | - | - | Stock Option | |
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 16,757 | 16,757 | - | - | Stock Option (right to buy) | |
| MeiraGTx Holdings plc | Joel S. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 15,000 | 15,000 | - | - | Restricted Share Units | |
| MeiraGTx Holdings plc | Joel S. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Applied Therapeutics Inc | Joel S. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2022 | 16,500 | 16,500 | - | - | Stock Option (Right to Buy) | |
| Alexandria Real Estate Equ... | Joel S. Marcus | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2022 | 2,500 | 346,026 (0%) | 0% | 0 | Common Stock | |
| Alexandria Real Estate Equ... | Joel S. Marcus | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 24,560 | 343,526 (0%) | 0% | 0 | Common Stock | |
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Sale of securities on an exchange or to another person at price $ 52.89 per share. | 07 Mar 2022 | 10,000 | 28,980 (0%) | 0% | 52.9 | 528,900 | Common Stock |
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Sale of securities on an exchange or to another person at price $ 54.52 per share. | 07 Mar 2022 | 5,000 | 43,980 (0%) | 0% | 54.5 | 272,600 | Common Stock |
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Sale of securities on an exchange or to another person at price $ 52.25 per share. | 07 Mar 2022 | 5,000 | 38,980 (0%) | 0% | 52.3 | 261,250 | Common Stock |
| Alexandria Real Estate Equ... | Joel S. Marcus | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2022 | 16,869 | 318,966 (0%) | 0% | 0 | Common Stock | |
| Alexandria Real Estate Equ... | Joel S. Marcus | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 207.61 per share. | 09 Aug 2021 | 7,500 | 302,097 (0%) | 0% | 207.6 | 1,557,075 | Common Stock |
| Alexandria Real Estate Equ... | Joel S. Marcus | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 202.63 per share. | 02 Aug 2021 | 5,000 | 309,597 (0%) | 0% | 202.6 | 1,013,150 | Common Stock |
| Alexandria Real Estate Equ... | Joel S. Marcus | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 200.00 per share. | 28 Jul 2021 | 15,000 | 314,597 (0%) | 0% | 200 | 3,000,000 | Common Stock |
| Alexandria Real Estate Equ... | Joel S. Marcus | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 200.02 per share. | 28 Jul 2021 | 5,000 | 329,597 (0%) | 0% | 200.0 | 1,000,100 | Common Stock |
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2021 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Frequency Therapeutics Inc | Joel S. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 14,846 | 14,846 | - | - | Stock Option | |
| MeiraGTx Holdings plc | Joel S. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 15,000 | 15,000 | - | - | Restricted Share Units | |
| MeiraGTx Holdings plc | Joel S. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Applied Therapeutics Inc | Joel S. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2021 | 16,500 | 16,500 | - | - | Stock Option (Right to Buy) | |
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 May 2021 | 13,767 | 13,767 (0%) | 0% | - | Common Stock | |
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 May 2021 | 13,767 | 0 | - | - | Restricted Stock Units | |
| Alexandria Real Estate Equ... | Joel S. Marcus | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 180.33 per share. | 03 May 2021 | 15,000 | 339,597 (0%) | 0% | 180.3 | 2,704,950 | Common Stock |
| Alexandria Real Estate Equ... | Joel S. Marcus | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 180.41 per share. | 03 May 2021 | 5,000 | 334,597 (0%) | 0% | 180.4 | 902,050 | Common Stock |
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Apr 2021 | 25,000 | 47,269 (0%) | 0% | 0 | Common Stock | |
| Alexandria Real Estate Equ... | Joel S. Marcus | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2021 | 21,310 | 366,992 (0%) | 0% | 0 | Common Stock | |
| Alexandria Real Estate Equ... | Joel S. Marcus | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 164.30 per share. | 31 Mar 2021 | 12,395 | 354,597 (0%) | 0% | 164.3 | 2,036,499 | Common Stock |
| Frequency Therapeutics Inc | Joel S. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Mar 2021 | 37,116 | 0 | - | - | Stock Option | |
| Frequency Therapeutics Inc | Joel S. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.37 per share. | 25 Mar 2021 | 37,116 | 307,116 (0%) | 0% | 3.4 | 125,081 | Common Stock |
| MeiraGTx Holdings plc | Joel S. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2021 | 12,882 | 0 | - | - | Stock Option (right to buy) | |
| MeiraGTx Holdings plc | Joel S. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.72 per share. | 15 Mar 2021 | 12,882 | 12,882 (0%) | 0% | 7.7 | 99,449 | Ordinary Shares |
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2021 | 20,000 | 0 | - | - | Stock Option (right to buy) | |
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.58 per share. | 02 Mar 2021 | 20,000 | 87,519 (0%) | 0% | 26.6 | 531,600 | Common Stock |
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Sale of securities on an exchange or to another person at price $ 34.93 per share. | 02 Mar 2021 | 15,250 | 72,269 (0%) | 0% | 34.9 | 532,683 | Common Stock |
| Alexandria Real Estate Equ... | Joel S. Marcus | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2021 | 21,251 | 345,682 (0%) | 0% | 0 | Common Stock | |
| Frequency Therapeutics Inc | Joel S. Marcus | Director | Sale of securities on an exchange or to another person at price $ 34.27 per share. | 18 Dec 2020 | 10,000 | 270,000 (0%) | 0% | 34.3 | 342,738 | Common Stock |
| Frequency Therapeutics Inc | Joel S. Marcus | Director | Sale of securities on an exchange or to another person at price $ 30.35 per share. | 18 Dec 2020 | 10,000 | 290,000 (0%) | 0% | 30.4 | 303,521 | Common Stock |
| Frequency Therapeutics Inc | Joel S. Marcus | Director | Sale of securities on an exchange or to another person at price $ 38.27 per share. | 18 Dec 2020 | 8,412 | 300,000 (0%) | 0% | 38.3 | 321,910 | Common Stock |
| Frequency Therapeutics Inc | Joel S. Marcus | Director | Sale of securities on an exchange or to another person at price $ 32.97 per share. | 18 Dec 2020 | 7,441 | 281,120 (0%) | 0% | 33.0 | 245,339 | Common Stock |
| Frequency Therapeutics Inc | Joel S. Marcus | Director | Sale of securities on an exchange or to another person at price $ 37.21 per share. | 18 Dec 2020 | 4,300 | 308,412 (1%) | 0% | 37.2 | 159,991 | Common Stock |
| Frequency Therapeutics Inc | Joel S. Marcus | Director | Sale of securities on an exchange or to another person at price $ 36.03 per share. | 18 Dec 2020 | 2,864 | 312,712 (1%) | 0% | 36.0 | 103,191 | Common Stock |
| Frequency Therapeutics Inc | Joel S. Marcus | Director | Sale of securities on an exchange or to another person at price $ 33.92 per share. | 18 Dec 2020 | 2,310 | 317,390 (1%) | 0% | 33.9 | 78,359 | Common Stock |
| Frequency Therapeutics Inc | Joel S. Marcus | Director | Sale of securities on an exchange or to another person at price $ 34.90 per share. | 18 Dec 2020 | 1,814 | 315,576 (1%) | 0% | 34.9 | 63,306 | Common Stock |
| Frequency Therapeutics Inc | Joel S. Marcus | Director | Sale of securities on an exchange or to another person at price $ 32.09 per share. | 18 Dec 2020 | 1,439 | 288,561 (0%) | 0% | 32.1 | 46,178 | Common Stock |
| Frequency Therapeutics Inc | Joel S. Marcus | Director | Sale of securities on an exchange or to another person at price $ 33.82 per share. | 18 Dec 2020 | 1,120 | 280,000 (0%) | 0% | 33.8 | 37,879 | Common Stock |
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Dec 2020 | 28,379 | 0 (0%) | 0% | 0 | Common Stock | |
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Dec 2020 | 28,379 | 67,519 (0%) | 0% | 0 | Common Stock | |
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Dec 2020 | 20,000 | 0 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges